Leerink and Oppenheimer acted as joint book running managers for the offering.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX:
- Promising Clinical Trial Results and Favorable Safety Profile Support Buy Rating for Immuneering
- Immuneering Announces $25M Securities Purchase Agreement
- Immuneering announces data from trial of atebimetinib combination
- Immuneering announces Class A common stock offering, private placement
- Immuneering appoints Schall as Chairman of the Board